Category: Neuropharmacology
Natural Killer Cells May Play a Role in Preventing Parkinson’s Disease
According to the Global Burden of Disease study, 6.2 million patients live with Parkinson’s disease (PD) and this number is expected to double by 2040.
MTBR-Tau-243 May Be an Indicator of Alzheimer’s Disease Progression
Alzheimer’s disease (AD), a disease of the neurological system, is the most common form of dementia. The early stages of AD affect the portions of
Brain Iron Deposits as a Predictive Measure of Dementia in Parkinson’s Disease
Parkinson’s Disease (PD) is a progressive neurodegenerative disease that causes neurons in the area of the brain that controls movement to weaken or die. Up
Advances in Drug Discovery for Central Nervous System Diseases
Discovering effective and safe new drugs depends on a detailed knowledge of disease mechanisms, as well as a successful progression from candidate identification to clinical
Marmosets as Primate Models of Familial Alzheimer’s Disease
The common marmoset, Callithrix jaccus, possesses complex social behaviors and sleep patterns that closely resemble those of humans. This South American monkey’s metabolism, immune systems,
Tau Propagation Influences the Pace of Alzheimer’s Disease Progression
Progressive cognitive impairments are a hallmark of Alzheimer’s Disease (AD), but the timing of their onset and progression varies by patient. Even among people with
